Literature DB >> 480453

In vitro translation of adenovirus type 12-specific mRNA isolated from infected and transformed cells.

H Esche, R Schilling, W Doerfler.   

Abstract

The early and late gene products of human adenovirus type 12 (Ad12), as well as the viral proteins synthesized in an Ad12-transformed cell line, were identified by translation of viral mRNA in an in vitro protein-synthesizing system. Cytoplasmic RNA was isolated from permissive KB or nonpermissive BHK cells infected with Ad12 and from Ad12-transformed HA12/7 cells. Virus-specific RNA was selected by hybridization to Ad12 DNA covalently bound to cellulose. Viral RNA was then translated in a fractionated rabbit reticulocyte cell-free system or in wheat germ S-30 extracts. The proteins synthesized were characterized by immunoprecipitation and subsequent electrophoresis on sodium dodecyl sulfate-polyacrylamide gels. RNA prepared from KB cells late after infection with Ad12 elicited the synthesis of most of the structural polypeptides of the virion and at least two presumably nonstructural Ad12 proteins. When viral RNA isolated early after infection of KB cells with Ad12 was translated in vitro, 10 polypeptides were observed: E-68K, E-50K, E-42K, E-39K, E-34K, E-21K, E-19K, E-13K, E-12K, and E-10K. Ad12-specific RNA was also isolated from the Ad12-transformed hamster cell line HA12/7, which contains several copies of the Ad12 genome integrated in the host genome. The RNA codes for at least seven polypeptides with molecular weights very similar to those of the early viral proteins.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 480453      PMCID: PMC353293     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Amino acid metabolism in mammalian cell cultures.

Authors:  H EAGLE
Journal:  Science       Date:  1959-08-21       Impact factor: 47.728

2.  SPECIFIC ADENOVIRUS COMPLEMENT-FIXING ANTIGENS IN VIRUS-FREE HAMSTER AND RAT TUMORS.

Authors:  R J HUEBNER; W P ROWE; H C TURNER; W T LANE
Journal:  Proc Natl Acad Sci U S A       Date:  1963-08       Impact factor: 11.205

3.  STUDIES ON THE MECHANISM OF POLIOVIRUS-INDUCED CELL DAMAGE. I. THE RELATION BETWEEN POLIOVIRUS,-INDUCED METABOLIC AND MORPHOLOGICAL ALTERATIONS IN CULTURED CELLS.

Authors:  R BABLANIAN; H J EGGERS; I TAMM
Journal:  Virology       Date:  1965-05       Impact factor: 3.616

4.  Plaque production by the polyoma virus.

Authors:  R DULBECCO; G FREEMAN
Journal:  Virology       Date:  1959-07       Impact factor: 3.616

5.  The cell-free synthesis of herpesvirus-induced polypeptides.

Authors:  C M Preston
Journal:  Virology       Date:  1977-05-01       Impact factor: 3.616

6.  The isolation and identification of the adenovirus group C tumor antigens.

Authors:  A Levinson; A J Levine
Journal:  Virology       Date:  1977-01       Impact factor: 3.616

7.  The group C adenovirus tumor antigens: identification in infected and transformed cells and a peptide map analysis.

Authors:  A D Levinson; A J Levine
Journal:  Cell       Date:  1977-08       Impact factor: 41.582

8.  Integrated viral sequences in adenovirus type 12-transformed hamster cells.

Authors:  J Groneberg; Y Chardonnet; W Doerfler
Journal:  Cell       Date:  1977-01       Impact factor: 41.582

9.  Intracellular forms of adenovirus DNA. V. Viral DNA sequences in hamster cells abortively infected and transformed with human adenovirus type 12.

Authors:  E Fanning; W Doerfler
Journal:  J Virol       Date:  1976-11       Impact factor: 5.103

10.  Patterns of integration of viral DNA sequences in the genomes of adenovirus type 12-transformed hamster cells.

Authors:  D Sutter; M Westphal; W Doerfler
Journal:  Cell       Date:  1978-07       Impact factor: 41.582

View more
  12 in total

1.  Nucleotide sequence of human adenovirus type 12 DNA: comparative functional analysis.

Authors:  J Sprengel; B Schmitz; D Heuss-Neitzel; C Zock; W Doerfler
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

2.  Early RNA of adenovirus type 3 in permissive and abortive infections.

Authors:  D E Groff; E Daniell
Journal:  J Virol       Date:  1981-11       Impact factor: 5.103

3.  Overlapping sets of viral RNAs reflect the array of polypeptides in the EcoRI J and N fragments (map positions 81.2 to 85.0) of the Autographa californica nuclear polyhedrosis virus genome.

Authors:  C Oellig; B Happ; T Müller; W Doerfler
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

4.  Adenovirus type 12-transformed rat embryo brain and rat liver epithelial cell lines: adenovirus type 12 genome content and viral protein expression.

Authors:  C Paraskeva; K W Brown; A R Dunn; P H Gallimore
Journal:  J Virol       Date:  1982-11       Impact factor: 5.103

5.  Identification of the very early transcribed baculovirus gene PE-38.

Authors:  R Krappa; D Knebel-Mörsdorf
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

6.  Proteins encoded in the 81.2- to 85.0-map-unit fragment of Autographa californica nuclear polyhedrosis virus DNA can be translated in vitro and in Spodoptera frugiperda cells.

Authors:  B Happ; J Li; W Doerfler
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

7.  Adenovirus types 2 and 5 functions elicit replication and late expression of adenovirus type 12 DNA in hamster cells.

Authors:  T Klimkait; W Doerfler
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

8.  Defect of adenovirus type 12 replication in hamster cells: absence of transcription of viral virus-associated and L1 RNAs.

Authors:  R Jüttermann; U Weyer; W Doerfler
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

9.  A mitigator sequence in the downstream region of the major late promoter of adenovirus type 12 DNA.

Authors:  C Zock; W Doerfler
Journal:  EMBO J       Date:  1990-05       Impact factor: 11.598

10.  The translational map of the Autographa californica nuclear polyhedrosis virus (AcNPV) genome.

Authors:  H Esche; H Lübbert; B Siegmann; W Doerfler
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.